SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI) -- Ignore unavailable to you. Want to Upgrade?

To: OldAIMGuy who wrote (615)2/14/2000 11:46:00 AM
From: joemjo  Respond to of 1154
 
Tom,

I took it as that segment of HGSI was the same as GENE's. So therefore if GENE had the same success in collaborations then GENE would receive the same value, again for that segment, not 1/3.



To: OldAIMGuy who wrote (615)2/14/2000 11:51:00 AM
From: OldAIMGuy  Read Replies (1) | Respond to of 1154
 
Hi J, To finish...........

If GENE achieved 1/3 the market cap of HGSI, then we'd have about $2.2 Billion. That's three times what we currently are showing. That would make GENE a $100+ stock.

Interesting........

Best regards, Tom


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News